Iodo    (DrugBank: iodo)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
28全身性アミロイドーシス2

28. 全身性アミロイドーシス [臨床試験数:212,薬物数:234(DrugBank:72),標的遺伝子数:54,標的パスウェイ数:170
Searched query = "Systemic amyloidosis", "AL amyloidosis", "Immunoglobulin light chain amyloidosis", "Amyloid light-chain amyloidosis", "Familial amyloidosis", "Familial amyloid polyneuropathy", "Senile transthyretin amyloidosis", "Senile TTR amyloidosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 212 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00030381
(ClinicalTrials.gov)
December 200114/2/2002Iododoxorubicin in Treating Patients With Primary Systemic AmyloidosisPhase I Trial of 4'-IODO-4'-Deoxydoxorubicin in Primary Amyloidosis (AL)Primary Systemic AmyloidosisDrug: 4'-iodo-4'-deoxydoxorubicin;Other: pharmacological studyNational Cancer Institute (NCI)NULLTerminated18 YearsN/ABoth22Phase 1United States
2NCT00003853
(ClinicalTrials.gov)
April 19991/11/19994'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic AmyloidosisPhase II Trial of 4'-IODO-4'-Deoxydoxorubicin in Primary Amyloidosis (AL)Multiple Myeloma and Plasma Cell NeoplasmDrug: 4'-iodo-4'-deoxydoxorubicinNational Cancer Institute (NCI)NULLCompleted18 YearsN/ABoth45Phase 2United States;Italy